These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8897451)

  • 1. Anatomical differences in responsiveness to vasoconstrictors in the mesenteric veins from normal and portal hypertensive rats.
    Moreno L; Martínez-Cuesta MA; Piqué JM; Bosch J; Esplugues JV
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):474-80. PubMed ID: 8897451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
    Heinemann A; Wachter CH; Holzer P; Fickert P; Stauber RE
    Br J Pharmacol; 1997 Jul; 121(5):1031-7. PubMed ID: 9222564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
    Heinemann A; Stauber RE
    J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta.
    Cawley T; Geraghty J; Osborne H; Docherty JR
    Br J Pharmacol; 1995 Feb; 114(4):791-6. PubMed ID: 7773539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats.
    Sogni P; Sabry S; Moreau R; Gadano A; Lebrec D; Dinh-Xuan AT
    J Hepatol; 1996 Apr; 24(4):487-90. PubMed ID: 8738736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive rats.
    Ramírez MC; Martínez-Cuesta MA; D'Ocon P; Noguera MA; García-Zaragoza E; Bosch J; Melin P; Esplugues JV
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):199-204. PubMed ID: 11521161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.
    Wiest R; Tsai MH; Groszmann RJ
    Gastroenterology; 2001 Mar; 120(4):975-83. PubMed ID: 11231951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats.
    Huang YT; Lin HC; Tsai JF; Hou MC; Lee SD; Hong CY
    J Hepatol; 1998 Jun; 28(6):1037-44. PubMed ID: 9672181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
    Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
    J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats.
    Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
    Eur J Pharmacol; 1995 Jan; 273(1-2):167-74. PubMed ID: 7537679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
    Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
    Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin reverses mesenteric hyperemia and vasoconstrictor hyporesponsiveness in anesthetized portal hypertensive rats.
    Heinemann A; Wachter CH; Fickert P; Trauner M; Stauber RE
    Hepatology; 1998 Sep; 28(3):646-54. PubMed ID: 9731553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide-mediated beta 2-adrenoceptor relaxation is impaired in mesenteric veins from portal-hypertensive rats.
    Martínez-Cuesta MA; Moreno L; Piqué JM; Bosch J; Rodrigo J; Esplugues JV
    Gastroenterology; 1996 Sep; 111(3):727-35. PubMed ID: 8780579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Portal hypertension increases vasoconstrictor responsiveness of rat aorta.
    Connolly C; Cawley T; McCormick PA; Docherty JR
    Clin Sci (Lond); 1999 Jan; 96(1):41-7. PubMed ID: 9857105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide.
    García-Estañ J; Atucha NM; Groszmann RJ
    J Hepatol; 1996 Aug; 25(2):206-11. PubMed ID: 8878783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamines relax portal and mesenteric veins from normal and portal hypertensive rats.
    Kaumann AJ; Groszmann RJ
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G977-81. PubMed ID: 2575356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related differences and roles of endothelial nitric oxide and prostanoids in angiotensin II responses of isolated, perfused mesenteric arteries and veins of rats.
    Konishi C; Naito Y; Saito Y; Ohara N; Ono H
    Eur J Pharmacol; 1997 Feb; 320(2-3):175-81. PubMed ID: 9059851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats.
    Karatapanis S; McCormick PA; Kakad S; Chin JK; Islam M; Jeremy J; Harry D; McIntyre N; Burroughs AK; Jacobs M
    Hepatology; 1994 Dec; 20(6):1516-21. PubMed ID: 7527005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced G-protein-induced relaxation in portal hypertensive rats: role of nitric oxide.
    Hou MC; Cahill PA; Zhang S; Redmond EM; Sitzmann JV
    Hepatology; 1997 Jul; 26(1):27-33. PubMed ID: 9214448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.